There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on AmpliTech Group (AMPG – Research Report) and Society Pass (SOPA – Research Report) with bullish sentiments.
AmpliTech Group (AMPG)
In a report released yesterday, Jack Vander Aarde from Maxim Group reiterated a Buy rating on AmpliTech Group, with a price target of $8.00. The company’s shares closed last Friday at $2.44.
According to TipRanks.com, Aarde is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AmpliTech Group with a $8.00 average price target.
See today’s best-performing stocks on TipRanks >>
Society Pass (SOPA)
In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on Society Pass, with a price target of $6.00. The company’s shares closed last Friday at $1.95, close to its 52-week low of $1.49.
According to TipRanks.com, Klee has 0 stars on 0-5 stars ranking scale with an average return of
Society Pass has an analyst consensus of Moderate Buy, with a price target consensus of $7.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMPG:
- Maxim Group Sticks to Its Hold Rating for ABM Industries (ABM)
- Analysts’ Top Technology Picks: AmpliTech Group (AMPG), Society Pass (SOPA)
- Worksport (WKSP) Receives a Buy from Maxim Group
- Analysts Are Bullish on Top Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Taysha Gene Therapies (TSHA)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Cochlear Limited (OtherCHEOF), Verve Therapeutics (VERV) and Allogene Therapeutics (ALLO)
